Human Oncology & Pathogenesis Program
The Kojo Elenitoba-Johnson and Megan Lim Lab
Research
Kojo S. Elenitoba-Johnson is the Chair of the Department of Pathology and Laboratory Medicine and a physician-scientist. Dr. Elenitoba-Johnson’s research focuses on the role of genomic and proteomic alterations in the pathogenesis of lymphomas.
Dr. Megan S. Lim is the Director of the Lymphoma Translational Research Program and Director of the Biofluid Biobank. Dr. Lim is a hematopathologist-scientist who studies the role of genomic and proteomic alterations in the pathogenesis of lymphoma.
The research interests of the Elenitoba-Johnson-Lim lab encompass genomic and functional proteomic approaches to discover novel mechanisms of lymphoma pathogenesis; development of conditional murine models for investigating the role of oncogenes and tumor suppressor genes in lymphocyte development and lymphomas genesis and translational research utilizing innovative genomic and mass spectrometry-based approaches focused on identification of novel genomic and proteomic targets for diagnostic and therapeutic applications.
Research Projects
Featured News
Publications Highlights
People
Lab Alumni
Open Positions
To learn more about available postdoctoral opportunities, please visit our Career Center
To learn more about compensation and benefits for postdoctoral researchers at MSK, please visit Resources for Postdocs